The Russian ambassador spoke about the attitude towards Sputnik V in the Netherlands

The attitude in the Netherlands to the Russian Sputnik V vaccine is good, but everyone is waiting for the European Medicines Agency (EMA) certification decision to be vaccinated, said Russian Ambassador Extraordinary and Plenipotentiary to the Netherlands Alexander Shulgin.

The Russian ambassador spoke about the attitude towards Sputnik V in the Netherlands

“The attitude towards our vaccine is good here, there were a lot of positive materials, but everyone here is waiting for the decision of the European Medicines Agency, which should certify our vaccine. I think if this happens, there will be many people who want to be vaccinated,” the ambassador said on the air of the TV channel. Russia 24″.

According to him, the decision of the Netherlands on the issue of mutual recognition of covid certificates will also depend on the position of Brussels.

“The Dutch are guided by the decisions taken by Brussels, respectively, if the European Commission and EU structures decide to introduce a common certificate, they will follow these calls,” the ambassador explained.

At the same time, he noted that the situation in the country from a sanitary and epidemiological point of view remains difficult, despite the fact that restrictions have recently begun to be lifted.

“It seems that they began to cancel the restrictions imposed, but we had to tighten the screws again: literally in the last week, the number of new infections has increased six times, primarily among people who are not old, among young people. Therefore, the restrictions that existed for coming to Holland , remain, now you just need to see how events will develop, “the ambassador said.

Since March 4, Sputnik V has been undergoing a gradual examination procedure at the European Medicines Agency EMA. Earlier, the media, citing sources, reported that the approval of the vaccine in the EU would be postponed due to the fact that the deadlines for submitting the requested information were not met.

At the same time, the press service of the Russian Direct Investment Fund (RDIF) reported that Sputnik V could receive registration in the EU within two months, the GCP (good clinical practice) EMA inspection was completed, the agency provided a positive review, and information about delays is not true.

The RDIF stressed that the timing of Sputnik V’s receipt of the EMA registration “has become the subject of constant speculation by the press, referring to anonymous sources of information.” The fund believes that such rumors “slow down the registration process.” The Fund stressed that they continue to work with the EMA as part of a rolling review of the registration dossier, which involves the gradual filing of documents upon request. The examination continues, there is no talk of any delays.

Comments:

comments powered by HyperComments